|
|
| (11) | Number of the document | C 2435024 |
| (68) | Number of the document | 2435024 |
| (21) | Application number for Supplementary Protection Certificate | PA 2021 511 |
| (22) | Date of filing the application | 2021-06-04 |
| (41) | Date of publication of the application | 2021-06-25 |
| Date of publication of SPC | 2022-06-27 | |
| (24) | Date of coming into effect of SPC | 2030-05-29 |
| (71) |
Pearl Therapeutics, Inc.,
200 Saginaw Drive, Redwood City, CA 94063,
US
|
| (73) |
Pearl Therapeutics, Inc.,
200 Saginaw Drive, Redwood City, CA 94063,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | EU/1/20/1498, 2020-12-09 |
| (94) | 2035-05-28 |
| (95) | Formoterolio (įskaitant bet kokias farmaciniu požiūriu priimtinas jo druskas, esterius, solvatus arba enatiomerus), glikopirolato (įskaitant bet kokias farmaciniu požiūriu priimtinas jo druskas, esterius, solvatus arba enantiomerus) ir budezonido (įskaitant bet kokias farmaciniu požiūriu priimtinas jo druskas, esterius, solvatus arba enatiomerus) derinys |
| SPC granted |